Keywords: oncologyBreast CancerCancer of PancreasCancer of LiverCancer of StomachCancer LiverCancer of RectumCancer of KidneyCancer of EsophagusCancer of CervixCancer of ColonCancer of LarynxLung CancerCancer ProstateCancer of NeckCancer of SkinNeuroendocrine TumorsMismatch Repair DeficiencyBRCA Gene RearrangementNon Hodgkin LymphomaLeukemiaNon Small Cell Lung CancerCholangiocarcinomaGlioblastomaCentral Nervous System TumorMelanomaUrothelial CarcinomaBladder CancerOvarian CancerEndometrial CancerTesticular CancerCOVIDMyelofibrosisMyeloproliferative NeoplasmMyeloproliferative DisordersFollicular LymphomaMantle Cell LymphomaMarginal Zone Lymphoma
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Not listed
Recruiting
Jan 1, 2018
2038-12 (estimated)
NIH awards 1
Annual award amounts. Total $400K.
NIH contract (government contract; not a grant and not an investment round) 75N91020C00016-0-9999-1 FY2020: $399,594 awarded for that fiscal year; activity N43 (OTHER_NIH); PI KURNAZ, SELIN; recipient as written: MASSIVE BIO, INC., NEW YORK, NY. SBIR Phase I T source ↗
Level (Entry/Mid/Senior/Executive) is estimated from the job title and required years of experience. Descriptions are short excerpts (about the first 60 words) of the posting plus skills picked out of it; use Read full posting for the complete text.